Pritesh Shah Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pritesh Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Pritesh Shah for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 19.25 | 12,500 | 240,625 | 25,000 | |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 80.06 | 100 | 8,006 | 76,976 | 77.1 K to 77 K (-0.13 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 79.41 | 3,857 | 306,288 | 77,076 | 80.9 K to 77.1 K (-4.77 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 78.68 | 2,455 | 193,150 | 80,933 | 83.4 K to 80.9 K (-2.94 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 77.28 | 2,800 | 216,376 | 83,388 | 86.2 K to 83.4 K (-3.25 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 76.39 | 2,710 | 207,017 | 86,188 | 88.9 K to 86.2 K (-3.05 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 75.04 | 578 | 43,372 | 88,898 | 89.5 K to 88.9 K (-0.65 %) |
| Jul 30 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 19.25 | 12,500 | 240,625 | 89,476 | 77 K to 89.5 K (+16.24 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 27.60 | 7,500 | 207,000 | 22,500 | |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 70.00 | 7,500 | 525,000 | 76,976 | 84.5 K to 77 K (-8.88 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 27.60 | 7,500 | 207,000 | 84,476 | 77 K to 84.5 K (+9.74 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 27.60 | 7,500 | 207,000 | 22,500 | |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 70.00 | 7,500 | 525,000 | 76,976 | 84.5 K to 77 K (-8.88 %) |
| Jul 22 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 27.60 | 7,500 | 207,000 | 84,476 | 77 K to 84.5 K (+9.74 %) |
| Jul 09 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 27.81 | 764 | 21,248 | 76,976 | 76.2 K to 77 K (+1.00 %) |